Research on development of diagnostic tests for the novel coronavirus disease (COVID-19)

  • Funded by Japan Agency for Medical Research and Development (AMED)
  • Total publications:0 publications

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2019
    2019
  • Funder

    Japan Agency for Medical Research and Development (AMED)
  • Principal Investigator

    Pending
  • Research Location

    Japan
  • Lead Research Institution

    National Institute of Infectious Diseases, Japan
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Diagnostics

  • Special Interest Tags

    N/A

  • Study Subject

    Clinical

  • Clinical Trial Details

    Unspecified

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

The research group will aim to develop the basic technology for use in rapid diagnostic test kits for SARS-CoV-2. The group will focus on molecular and antibody based diagnostic technologies such as RT-LAMP, SARS-CoV-2 antigen detection assay, and anti-viral antibody detection assay. The group will also conduct viral genome analysis using clinical samples to develop robust diagnostic tests for SARS-CoV-2